Follicular lymphoma: refining prognostic models and impact of pod-24 in clinical outcomes (2022)
Source: Clinical lymphoma myeloma & leukemia. Unidade: FM
Subjects: PROGNÓSTICO, MARCADORES BIOLÓGICOS, LINFOMA
ABNT
NOGUEIRA, Daniel Silva et al. Follicular lymphoma: refining prognostic models and impact of pod-24 in clinical outcomes. Clinical lymphoma myeloma & leukemia, v. 22, n. 2, p. 67-75, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.clml.2021.08.004. Acesso em: 01 jun. 2024.APA
Nogueira, D. S., Lage, L. A. de P. C., Culler, H. F., & Pereira, J. (2022). Follicular lymphoma: refining prognostic models and impact of pod-24 in clinical outcomes. Clinical lymphoma myeloma & leukemia, 22( 2), 67-75. doi:10.1016/j.clml.2021.08.004NLM
Nogueira DS, Lage LA de PC, Culler HF, Pereira J. Follicular lymphoma: refining prognostic models and impact of pod-24 in clinical outcomes [Internet]. Clinical lymphoma myeloma & leukemia. 2022 ; 22( 2): 67-75.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.clml.2021.08.004Vancouver
Nogueira DS, Lage LA de PC, Culler HF, Pereira J. Follicular lymphoma: refining prognostic models and impact of pod-24 in clinical outcomes [Internet]. Clinical lymphoma myeloma & leukemia. 2022 ; 22( 2): 67-75.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.clml.2021.08.004